Progenics Pharmaceuticals, Inc. (PGNX) Reports In-Line Q2 EPS

August 9, 2012 7:36 AM

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q2 EPS of ($0.32) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found